Armata Pharmaceuticals (ARMP) Asset Utilization Ratio (2014 - 2020)

Armata Pharmaceuticals (ARMP) posted Asset Utilization Ratio of 0.0 for Q2 2020, down 72.9% sequentially from 0.01 in Q4 2017.

Armata Pharmaceuticals (ARMP) Asset Utilization Ratio (2014 - 2020) Analysis & Trends

Armata Pharmaceuticals has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q2 2020.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 0.0 (changed N/A YoY) and the FY2017 annual result came in at 0.01, down 25.03% from the prior year.
Asset Utilization Ratio retreated to 0.0 in Q2 2020 per ARMP's latest filing, from 0.01 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.02 in Q2 2016 and troughed at 0.0 in Q2 2020.
A 3-year average of 0.01 and a median of 0.01 in 2017 frame the typical range for Asset Utilization Ratio.
The sharpest annual moves came in 2016 and 2017: Asset Utilization Ratio soared 53.3% in 2016, then sank 55.98% in 2017.
Over 3 years, Asset Utilization Ratio stood at 0.01 in 2016, then retreated by 21.57% to 0.01 in 2017, then sank by 72.9% to 0.0 in 2020.
According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.01, and 0.01 for Q2 2020, Q4 2017, and Q3 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.93 Bn	131.08 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	86.11 Bn	78.11 Bn	3.93 Bn	0.38
3	Argenx Se	65.43 Bn	60.25 Bn	1.37 Bn	-
4	Moderna	56.09 Bn	50.96 Bn	52.00 Mn	0.20
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	0.90
7	BioNTech SE	27.68 Bn	9.29 Bn	668.28 Mn	0.13
8	Insmed	27.49 Bn	26.32 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	0.13
10	Armata Pharmaceuticals	180.43 Mn	156.43 Mn	-	-

Download Data